1. Kastango ES, DeMarco S. Pharmacy cleanroom project management considerations: an experience-based perspective.Int J Pharm Compd 2001; 5:221-5.
2. Understanding Pharmaceutical Cleanroom Design. Zhang J. ASHRAE J. September 2004; 29-33.
3. Analysing aseptic preparation - workload measurement and capacity planning. Gandy R; Beaumont I. Hosp Pharm. 2003; 10:338,340,343,345-347
4. Analysing aseptic preparation: survey design and data assessment. Gandy R; Beaumont I. Hosp Pharm. 2003; 10:328-330,333,335,337.
5. An ounce of prevention: controlling hazards in extemporaneous compounding practices. Kastango ES; Trissel LA; Bradshaw BD. Int J Pharm Compound. 2003; 7: 401-411.
6. Product containment in the compounding laboratory. Vidrine E. Int J Pharm Compound. 2003; 7:213-214.
7. Autoclaves and the sterilization of compounded parenteral products. Bledsoe PE, Wepfer S. Clean-Rooms 2002; 16:30-31.
8. Sterile-product compounding: comparison of ASHP and USP guidelines. Lima HA. Int J Pharm Compound. 1999; 3:270-273.
9. Improving the management, operations, and cost effectiveness of sterile-product compounding. Kastango ES, Douglass K. Int J Pharm Compound. 1999; 3: 253-8.
10. NABP Guidelines: Good Compounding Practices Applicable to State-Licensed Pharmacies. Int J Pharm Compound. 1997; 1:75-7.
11. The potential impact of USP general chapter 797 on procedures and requirements for the preparation of sterile radiopharmaceuticals. Hung JC. J Nucl Med. 2004 Jun;45(6):21N-6N.

For more resources, also see the ASHP Discussion Guide for Compounding Sterile Preparations [PDF]